|
|
【FINTEC 0150 交流专区】（前名 ASIABIO）
[复制链接]
|
|
|
发表于 14-11-2013 08:31 PM
|
显示全部楼层
今天又跌到0.115！！！ |
|
|
|
|
|
|
|
|
|
|
|
发表于 15-11-2013 03:10 AM
|
显示全部楼层
icy97 发表于 12-11-2013 04:21 AM 
宜鼎成立公司聯營生物質處理科技業務
2013-11-12 17:08
| ASIA BIOENERGY TECHNOLOGIES BERHAD |
Type | Announcement | Subject | TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS | Description | ASIA BIOENERGY TECHNOLOGIES BERHAD (“ASIABIO” OR THE “COMPANY”)
SHAREHOLDERS’ AGREEMENT BETWEEN AT SYSTEMIZATION BERHAD AND ASIABIO IN RELATION TO THE SET UP OF BIOMASS PROCESSING TECHNOLOGIES BUSINESS UNIT VIA YELLOW CHOICE SDN BHD | We refer to the Company’s announcement dated 11 November 2013.
We wish to amend or add the following:
FINANCIAL EFFECTS (amendment) The revised new paragraph should read as follows:
The Shareholders’ Agreement will not have any effect on the share capital, shareholdings of major shareholders, net assets per share, gearing and dividend policy of AsiaBio Group. The Shareholders’ Agreement is not expected to have any immediate material effect on the earnings of the Company for the financial year ending 31 January 2014 but anticipated to contribute positively to the Group in the long term.
There are no liabilities, including contingent liabilities or guarantees expected to be assumed by AsiaBio for the Shareholders’ Agreement.
SOURCE OF FUNDING (additional) The source of funds for AsiaBio’s investment in Yellow Choice Sdn Bhd will be from the Group’s technology incubator funds.
This announcement is dated 13 November 2013. |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 7-12-2013 02:26 AM
|
显示全部楼层
亚洲生化第3季亏190万
财经新闻 财经 2013-12-06 10:19
（吉隆坡5日讯）受高行政成本影响，亚洲生化（ASIABIO，0150，创业板）2014财政年第三季（截至10月31日止）亏损扩大至190万8000令吉，营业额则扬181%，报77万令吉。
首九个月而言，亏损则是收窄至91万4000令吉；营业额扩大4.9%，至143万4000令吉。
展望未来，该公司将致力于专注高科技业务，特别是与“绿色”
相关的项目，如油棕树桐项目，估计会在末季开始营运。
亚洲生化董事局表示，未来将持续面临挑战，因全球经济环境仍不稳定。[南洋网财经]
SUMMARY OF KEY FINANCIAL INFORMATION
31/10/2013 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 31/10/2013 | 31/10/2012 | 31/10/2013 | 31/10/2012 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 770 | 274 | 1,434 | 1,367 | | 2 | Profit/(loss) before tax | -1,914 | -434 | -976 | -2,227 | | 3 | Profit/(loss) for the period | -1,915 | -449 | -977 | -2,242 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -1,908 | -458 | -914 | -2,233 | | 5 | Basic earnings/(loss) per share (Subunit) | -0.48 | -0.12 | -0.23 | -0.58 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.0552 | 0.0531 |
本帖最后由 icy97 于 7-12-2013 04:46 PM 编辑
|
|
|
|
|
|
|
|
|
|
|
|
发表于 14-12-2013 03:23 AM
|
显示全部楼层
| ASIA BIOENERGY TECHNOLOGIES BERHAD |
Particulars of substantial Securities HolderName | Deutsche Bank AG | Address | 12 Taunusanlage, 60325 Frankfurt am Main, Hessen, Germany | NRIC/Passport No/Company No. | HRB30000 | Nationality/Country of incorporation | Germany | Descriptions (Class & nominal value) | Ordinary Shares of RM0.10 each | Date of cessation | 09/12/2013 | Name & address of registered holder | DB (Malaysia) Nominee (Asing) Sdn Bhd
8 Jalan Sultan Ismail, Menara IMC
Level 18-20, 50250 Kuala Lumpur, Malaysia | Currency | Malaysian Ringgit (MYR) | Number of securities disposed | 3,775,000 | Price Transacted ($$) |
| | Circumstances by reason of which a person ceases to be a substantial securities Holder | Disposal of shares in open market | Nature of interest | Direct | Date of notice | 13/12/2013
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 16-12-2013 08:45 AM
|
显示全部楼层
|
Deutsche Bank AG 大股东丢票了。。。Asiabio and AT 这对难兄难弟 |
|
|
|
|
|
|
|
|
|
|
|
发表于 23-12-2013 02:15 PM
|
显示全部楼层
这股有什么前景呢？如果研发可以取代汽油的产品，那就好了 |
|
|
|
|
|
|
|
|
|
|
|
发表于 21-2-2014 01:58 AM
|
显示全部楼层
亞洲生物能源 擬7億建綠能煉油產
企業財經20 Feb 2014 22:10
報導：凌枝棉
（吉隆坡20日訊）亞洲生物能源（ASIABIO，0150，創業板貿易股）與美國節能科技公司Cool Planet，簽署廠房建設合約，未來將物色聯營伙伴集資約2億1000萬美元（約7億令吉），建設3間綠能煉油產。
亞洲生物能源也是我國首家獲授權建設Cool Planet綠能煉油產的公司，生產高液體碳化氣RON105。
亞洲生物能源執行董事呂金龍指出，附屬公司Nexfuel正與幾家大型種植公司洽談聯營計劃，希望能夠在今年達成協議。
“一旦與聯營夥伴達成協議，我們將共同斥約2億1000萬美元（約7億令吉）建設3間綠能煉油產，生產約3800萬公升綠色汽油，也就是高液體碳化氣RON105。”
他今日接受記者專訪時，如是指出；列席者包括Cool Planet能源系統策略規劃副總裁阿埃利翁博士和亞洲生物能源主席拿督黃順偉。
呂金龍指出，公司計劃在柔佛興建其中2間綠能煉油產，並在彭亨州或北部建設另外一間；建設工程料能在明年底或2016年初竣工。”
“我們將使用油棕園生產的廢料和空鮮果串提煉RON105油氣，由于原料成本不高，提煉成本相當低，每公升僅達1.30令吉。”
他說，公司計劃把提煉的汽油100%出口海外，迄今已確認自願買家，大部分都是Cool Planet的股東。RON105每公升的售價將是3令吉。
副產品保護環境
助農民獲更高回酬
呂金龍指出，該綠能煉油產的功能除了使用生物原料生產RON105汽油，也將生產一種“負極碳”的副產品，名為“生物碳”（Biochar）。
他解釋：“若能把生物碳和有效的微生物同時用于種植，相信這能進一步幫助農民獲得更高回酬增長。”
阿埃利翁指出，這些植物也將大量吸收在空氣中漂流的碳，達到“負碳”效果，以確保大自然環境能受保護。
“RON105汽油能供汽車及航空業使用，當汽油供應商把這高品質的汽油混進低質量汽油時，就可生產出更有效的RON95和RON97汽油，讓消費者受惠。”
他指出，Cool Planet不會參與生產RON105汽油和“生物碳”的過程，僅負責提供該提煉廠所使用的科技。
呂金龍說：“我們將支付專利權使用費給Cool Planet，但還在洽談中。”
他認為，此創新科技能改變世界對汽油的看法，並直接推動公司的業務成長。【中国报财经】
| ASIA BIOENERGY TECHNOLOGIES BERHAD |
Type | Announcement | Subject | TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS | Description | ASIA BIOENERGY TECHNOLOGIES BERHAD (“ASIABIO” OR THE “COMPANY”)
• SUBSCRIPTION OF 20% EQUITY INTEREST IN NEXFUEL LIMITED (“NEXFUEL”)
• SIGNING OF PLANT CONSTRUCTION AND LICENSING AGREEMENT BETWEEN NEXFUEL AND COOL PLANET ENERGY SYSTEMS, INC. (“COOL PLANET”) FOR BIOMASS TO HIGH OCTANE GASOLINE TECHNOLOGY | The Board of Directors of AsiaBio is pleased to announce that the Company has on 20 February 2014 entered into a Subscription Agreement with Nexfuel Limited (“Nexfuel”) for the subscription of 25,000 new ordinary shares of USD1.00 each representing 20% equity stake in Nexfuel for an aggregate cash consideration sum of USD200,000.00 (“Subscription”).
The Subscription was made in connection with the signing of a Plant Construction Agreement between Nexfuel and Cool Planet Energy Systems, Inc. (“Cool Planet”), a United States-based clean technology company with strong multinational companies investor base that includes BP, Google Ventures, Energy Technology Ventures (GE, ConocoPhillips, NRG Energy) and the Constellation division of Exelon, that secures Nexfuel the licensing rights to Cool Planet’s technology in the development of fuel production plants in Malaysia. Nexfuel is the first company to receive such licensing rights outside of the United States.
Under the terms of the Plant Construction Agreement, Nexfuel shall be responsible for securing funds, feedstocks, permits and approval required for the building of Cool Planet’s Green Gasoline plants in Malaysia with its identified partners. Nexfuel shall also have fabrication rights for certain sections of the plant. The plant is estimated to cost USD70 million (equivalent to approximately RM230.9 million) for the total production of 10 million gallons of Green Gasoline.
About Nexfuel Nexfuel is a company incorporated in Labuan, Malaysia with a paid up share capital of USD100,000 comprising 100,000 ordinary shares of USD1.00 each and is involved in the provision of biomass processing and phytonutrients processing technologies. It is part of the AsiaBio Group. Nexfuel is a wholly owned subsidiary of Nexfuel Sdn Bhd, of which AsiaBio holds a 19% stake.
About Cool Planet Cool Planet is a proprietor of a fuel processing technology that is able to convert non-food biomass into high-octane, dropin biofuels (gasoline). Cool Planet’s conversion process also produces a by-product called biochar, a solid material that is obtained through the carbonization of the biomass. Biochar, when blended with soil, has the unique ability to vastly improve plant harvests while reducing the amount of water and fertilizer needed. The process can be carbon negative, capable of removing over 100 percent of the carbon footprint for every gallon used, thus reversing the consequences of the use of fossil fuels.
Cool Planet’s technology has a broad portfolio of pending and granted patents.
The Subscription is not expected to have any material effect on the earnings per share of AsiaBio Group for the financial year ended 31 January 2014, share capital, major shareholders’ shareholdings, net assets per share, gearing and dividend policy of AsiaBio Group. Nonetheless, the Subscription is expected to contribute positively to the future earnings of the Company once the collaboration between Nexfuel and Cool Planet is fully in works.
There are no liabilities, including contingent liabilities or guarantees, expected to be assumed by AsiaBio from the Subscription.
None of the Directors and major shareholders of AsiaBio and person(s) connected to them have any direct or indirect interest in the Subscription.
The highest percentage ratio applicable to the Subscription pursuant to Rule 10.02(g) of the ACE Market Listing Requirements of Bursa Malaysia Securities Berhad is 2.44%.
A copy of the Subscription Agreement is available for inspection at the office of AsiaBio during normal business hours from Monday to Friday (except public holidays) at A-3A09, Oasis Ara Damansara, No. 2, Jalan PJU 1A/7A, 47301 Petaling Jaya, Selangor Darul Ehsan, Malaysia for a period of three (3) months from the date of this announcement.
This announcement is dated 20 February 2014. |
本帖最后由 icy97 于 21-2-2014 04:19 AM 编辑
|
|
|
|
|
|
|
|
|
|
|
|
发表于 2-3-2014 03:06 AM
|
显示全部楼层
推动绿色项目 亚洲生化冀业绩转好
财经新闻 财经 2014-03-01 12:06
(吉隆坡28日讯）亚洲生化（ASIABIO，0150，创业板）执行董事陈石义认为，在推动更多绿色相关项目之际，下财年业绩预计会转好。
亚洲生化截至2013年10月31日财政年第3季的亏损，因营运成本增加而扩大至190万8000令吉。同期营业额则扬181%，报77万令吉。
首9个月而言，亏损则是收窄至91万4000令吉；营业额扩大4.9%，至143万4000令吉。
陈石义在结束股东特别大会后对《南洋商报》说，来年业绩料比去年好。
“我们并非一家贸易营销公司，我们是一家科技投资公司。
很多的投资都是无法马上看见回报，除了需要投下资金，也必须耐心等候。
“但是，我对公司接下来的前景，以及手上的投资回酬很有信心。”
亚洲生化在2月20日宣布，联号公司Nexfuel有限公司与美国洁能科技公司CoolPlanet合作，在马投资7000万美元（2亿3090万令吉）打造绿能炼油厂，这也是该公司首度授权予美国以外的公司。
绿能炼油厂 后年投产
陈石义表示：“虽然这项合作计划未能在一两年内看见回报。不过，一旦在2016年竣工投产后，相信可改变全球的汽油业，进而推动公司增长。”
他也披露，已为上述厂房选定数个理想地点。
“我们要在物流输送方便的地区设厂，希望选择靠近码头的地方，或者在彭亨和柔佛地区。”
亚洲生化股东也在今天的股东特别大会上，批准附加股和送凭单计划，集资最高4202万令吉，作为日后投资和营运资本。【南洋网财经】
|
|
|
|
|
|
|
|
|
|
|
|
发表于 14-3-2014 02:29 AM
|
显示全部楼层
| ASIA BIOENERGY TECHNOLOGIES BERHAD |
EX-date | 26/03/2014 | Entitlement date | 28/03/2014 | Entitlement time | 05:00:00 PM | Entitlement subject | Rights Issue | Entitlement description | RENOUNCEABLE RIGHTS ISSUE OF UP TO 420,200,000 NEW ORDINARY SHARES OF RM0.10 EACH IN ASIA BIOENERGY TECHNOLOGIES BERHAD ("ASIABIO")(“RIGHTS SHARES”) TOGETHER WITH UP TO 420,200,000 FREE DETACHABLE WARRANTS (“WARRANTS”) ON THE BASIS OF ONE (1) RIGHTS SHARE FOR EVERY ONE (1) EXISTING ORDINARY SHARE OF RM0.10 EACH IN ASIABIO TOGETHER WITH ONE (1) WARRANT FOR EVERY ONE (1) RIGHTS SHARE SUBSCRIBED IN ASIABIO AT 5.00 P.M. ON 28 MARCH 2014 AT AN ISSUE PRICE OF RM0.10 PER RIGHTS
SHARE PAYABLE IN FULL UPON ACCEPTANCE ("RIGHTS ISSUE WITH WARRANTS") | Period of interest payment | to | Financial Year End |
| | Share transfer book & register of members will be | to closed from (both dates inclusive) for the purpose of determining the entitlements | Registrar's name ,address, telephone no | Tricor Investor Services Sdn Bhd
Level 17, The Gardens North Tower
Mid Valley City
Lingkaran Syed Putra
59200 Kuala Lumpur
Telephone number: 03-2264 3883 | Payment date |
| | a.Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers | 28/03/2014 | b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit |
| | c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange. | Number of new shares/securities issued (units) (If applicable) | 420200000 | Entitlement indicator | Ratio | Ratio | 1 : 1 | Rights Issues/Offer Price | 0.1 |
Despatch Date | 01/04/2014 | Date for commencement of trading of the rights | 31/03/2014 | Date for despatch of abridged prospectus and subscription forms | 01/04/2014 | Date for cessation of trading of the rights | 07/04/2014 | Date for announcement of final subscription result and basis of allotment of excess Rights Securities | 21/04/2014 | Listing date of the Rights Securities | 28/04/2014 |
| Last date and time for | Date | Time | | Sale of provisional allotment of rights | 04/04/2014 | at | 05:00:00 PM | | Transfer of provisional allotment of rights | 09/04/2014 | at | 04:00:00 PM | | Acceptance and payment | 14/04/2014 | at | 05:00:00 PM | | Excess share application and payment | 14/04/2014 | at | 05:00:00 PM
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 21-3-2014 04:19 PM
|
显示全部楼层
icy97 发表于 14-3-2014 02:29 AM
这个股可以买进吗？ |
|
|
|
|
|
|
|
|
|
|
|
发表于 21-3-2014 05:58 PM
|
显示全部楼层
chloetee820 发表于 21-3-2014 04:19 PM
这个股可以买进吗？
oh 好的，不明白在问你 |
|
|
|
|
|
|
|
|
|
|
|
发表于 29-3-2014 05:47 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31/01/2014 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 31/01/2014 | 31/01/2013 | 31/01/2014 | 31/01/2013 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 2,266 | 946 | 3,700 | 2,313 | | 2 | Profit/(loss) before tax | 267 | -2,090 | -709 | -4,317 | | 3 | Profit/(loss) for the period | 267 | -2,161 | -710 | -4,403 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | 269 | -2,161 | -645 | -4,394 | | 5 | Basic earnings/(loss) per share (Subunit) | 0.07 | -0.57 | -0.16 | -1.15 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.0559 | 0.0531 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 12-4-2014 05:23 PM
|
显示全部楼层
|
ASIABIO - OR (0150OR)为什么没了？ |
|
|
|
|
|
|
|
|
|
|
|
发表于 13-4-2014 12:14 PM
|
显示全部楼层
kong_88 发表于 12-4-2014 05:23 PM
ASIABIO - OR (0150OR)为什么没了？
版主，谢谢你的解释~
|
|
|
|
|
|
|
|
|
|
|
|
发表于 18-4-2014 03:03 AM
|
显示全部楼层
亚洲生物科技 售燃料予宏国能源
财经 2014年4月17日
（吉隆坡17日讯）亚洲生物能源科技（ASIABIO，0150，创业板）透过附属公司，Nexfuel有限公司与与新加坡原油和精炼產品贸易公司--宏国能源（Concord ENERGY），签署生物燃料採购协议，以发展在大马的燃料生產厂。
宏国能源將买入所有由亚洲生物能源联號公司--NexFuel旗下公司利用美国Cool Planet能源系统公司所生產的生物燃料。
根据该协议，宏国能源將购买全数由绿能炼油厂生產的生物燃料產品。这项协议將会从第一家绿能炼油厂的首批交易开始生效，为期6年。
一旦绿能炼油厂开始运作，预计能为该公司作出正面的盈利贡献。
Nexfuel在2014年2月20日与美国Cool Planet签订厂房建设合约(Plant Construction Agreement)，並授权Nexfuel在马来西亚使用其科技发展燃料製造厂房。
亚洲生物能源科技今日大热走高，闭市上涨1仙或10.53%，至0.105令吉，成交量达1亿3717万股，是今日第2大热门股。【东方网财经】
Type | Announcement | Subject | TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS | Description | ASIA BIOENERGY TECHNOLOGIES BERHAD (“ABT” OR THE “COMPANY”)
• SIGNING OF BIOFUELS OFFTAKE AGREEMENT BETWEEN NEXFUEL LIMITED (“NEXFUEL”) AND CONCORD ENERGY PTE. LTD. (“CONCORD”) | 1. Introduction The Board of Directors of ABT is pleased to announce that its associated company, Nexfuel has on 16 April 2014 entered into a Biofuels Offtake Agreement (“Agreement”) with Concord for the offtake sale of all of the biofuels products to be produced by one or more subsidiaries to be established under Nexfuel using the technology developed by Cool Planet Energy Systems, Inc. (“Cool Planet”) (each, a “Project Company”).
The Agreement is signed following the Plant Construction agreement which was previously signed between Nexfuel and Cool Planet on 20 February 2014, giving Nexfuel the licensing rights to Cool Planet’s technology to develop fuel production plants in Malaysia (“Cool Planet Technology”). Nexfuel intends to establish via the Project Companies, one or more of such fuel production plants with the first targeted to be completed by year 2016.
2. Information on Concord From its inception in 1998, Concord has grown to become one of Singapore and South East Asia’s leading crude oil and refined products trading companies. Today, based in Singapore, Concord Energy Group is an organization that is constantly developing new aspects of its business as it evolves into an integrated, asset-based energy company.
Headquartered in Singapore, Concord has offices in Dubai, Indonesia, Malaysia, Switzerland, China and United Kingdom.
3. Information on Nexfuel Nexfuel is a company incorporated in Labuan, Malaysia with a paid up share capital of USD125,000 comprising 125,000 ordinary shares of USD1.00 each and is involved in provision of biomass processing and phytonutrients processing technologies. Nexfuel is a 20% associated company of ABT.
4. Information on Cool Planet Cool Planet is a proprietor of a fuel processing technology that is able to convert non-food biomass into high-octane, dropin biofuels (gasoline). Cool Planet’s conversion process also produces a by-product called biochar, a solid material that is obtained through the carbonization of the biomass. Biochar, when blended with soil, has the unique ability to vastly improve plant harvests while reducing the amount of water and fertilizer needed. The process can be carbon negative, capable of removing over 100 percent of the carbon footprint for every gallon used, thus reversing the consequences of the use of fossil fuels.
Cool Planet’s technology has a broad portfolio of pending and granted patents.
5. Salient Features of the Agreement Salient features of the Agreement include the following:-
a) In accordance to the Agreement, Nexfuel will cause each Project Company to sell, and the Buyer will purchase, all of the biofuel products produced at its Facility.
b) This Agreement will be effective as of the Effective Date and, without prejudice to terms relating to the early termination of this Agreement, shall endure until the sixth (6th) anniversary of the date of completion of the first delivery of Product from the first Facility of the first Project Company.
c) The pricing of which is to be referenced to the monthly average of mid daily quotations as published in Platts Asia Pacific / Arab Gulf Marketscan under the heading ‘Singapore’ (“Platts Singapore”).
d) Project Company will provide Buyer, on the Commencement of Production and by the 20th day of each calendar month thereafter, a rolling schedule for the following twelve (12) months specifying the amount of each Product that Project Company anticipates, in good faith, delivering to Buyer from the Facility for each month of that twelve (12) month period.
e) The grade and specifications of the Product delivered shall be determined by reference to the results of sampling and analysis of the Product carried out by an Inspector, appointed and paid for jointly by the Project Company and the Buyer.
f) The Agreement and its construction, validity and performance and any non-contractual obligations arising from or connected with it shall be governed by the laws of England and Wales to the exclusion of any other law. For the avoidance of doubt, the United Nations Convention on Contracts for the International Sale of Goods of Vienna, 11 April 1980, and any law enacting or giving force to the same or any parts of it, shall not apply to the Agreement.
The definitions used in this section are as follows:-
“Buyer” means Concord or a nominated Affiliate of Concord;
“Commencement of Production” means, in respect of a specific Facility, the date on which the Project Company, acting in good faith, notifies the Buyer that commissioning and testing of the Facility has been successfully completed and commercial production of one or more Products has commenced at the Facility or, in the absence of any such notification, the first date by which the total aggregated amount of Product produced at the Facility is equal to or greater than the minimum delivery amount as specified in the Agreement for the Facility;
“Effective Date” means the date on which the Agreement is signed by both parties;
“Facility” means any and all facilities of a specific Project Company that are located in Malaysia, whether existing now or in the future, and at which Products are produced using the Cool Planet Technology;
“Products” means the products identified as the distilled blend stock, raw blend stock (which includes all biofuel products other than distilled blend stock that are in the opinion of the Buyer suitable to be marketed for sale in the gasoline market) and other useful products (which includes all biofuel products, other than distilled blend stock or raw blend stock, such as benzene, jet/kerosene/diesel blend stocks, and lubricant blend stocks), produced at any Facilities that are in the opinion of the Buyer suitable to be marketed for sale in the refined petroleum products market.
6. Effects of the Agreement The Agreement is not expected to have any material effect on the earnings per share of ABT Group for the financial year ending 31 January 2015, share capital, major shareholders’ shareholdings, net assets per share, gearing and dividend policy of ABT Group. Nonetheless, the Agreement is expected to contribute positively to the future earnings of the Company once the Project Companies are in place.
There are no liabilities, including contingent liabilities or guarantees, expected to be assumed by ABT from the Agreement.
7. Approvals Required The Agreement is not subject to approval of the shareholders of ABT and relevant authorities.
8. Directors’ and Major Shareholders’ Interest None of the Directors and major shareholders of ABT and person(s) connected to them have any direct or indirect interest in the Agreement.
9. Statement by Board The Board of Directors of ABT is of the opinion that the Agreement is in the best interest of ABT.
A copy of the Agreement is available for inspection at the registered office of ABT during normal business hours from Monday to Friday (except public holidays) at B-11-10, Level 11 Megan Avenue II, Jalan Yap Kwan Seng, 50450 Kuala Lumpur for a period of three (3) months from the date of this announcement.
This announcement is dated 17 April 2014. |
本帖最后由 icy97 于 18-4-2014 03:42 AM 编辑
|
|
|
|
|
|
|
|
|
|
|
|
发表于 19-4-2014 04:54 AM
|
显示全部楼层
亞洲生物能源附加股超額認購
財經20 Apr 2014 15:19
（吉隆坡20日訊）亞洲生物能源（ASIABIO，0150，創業板貿易股）附加股送憑單計劃，獲得108.06%認購率。
亞洲生物能源在文告指出，上述附加股總數達4億2020萬股，發售价為每股10仙，預計本月28日于大馬交易所創業板掛牌。
亞洲生物能源執行董事呂金龍在文告中指出：“附加股認購率令人鼓舞，證明股東們對我們的商業前景和經營模式充滿信心。”
“身為一家科技技術研發公司，我們著重于開發与培育新的商業點子。透過合适的人際交涉、科技与金融專業知識，我們相信有能力實踐具有潛力的業務概念。”
在這項企業活動下，每持1股現有股的股東，將可認購1股附加股，發售高達4億2020萬股附加股。該公司也以每持1股附加股，配送1憑單的比例，發送4億2020萬憑單。
上述附加股活動將籌集4202萬令吉，其中4102萬令吉將用作技術研發的開銷。【中国报财经】
| ASIA BIOENERGY TECHNOLOGIES BERHAD |
Type | Announcement | Subject | NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
FUND RAISING | Description | ASIA BIOENERGY TECHNOLOGIES BERHAD (“ASIABIO” OR THE “COMPANY”)
RENOUNCEABLE RIGHTS ISSUE OF 420,200,000 NEW ORDINARY SHARES OF RM0.10 EACH IN ASIABIO (“RIGHTS SHARES”) TOGETHER WITH 420,200,000 FREE DETACHABLE WARRANTS (“WARRANTS”) ON THE BASIS OF ONE (1) RIGHTS SHARE FOR EVERY ONE (1) EXISTING ORDINARY SHARE OF RM0.10 EACH IN ASIABIO TOGETHER WITH ONE (1) WARRANT FOR EVERY ONE (1) RIGHTS SHARE SUBSCRIBED IN ASIABIO AT 5.00 P.M. ON 28 MARCH 2014 AT AN ISSUE PRICE OF RM0.10 PER RIGHTS SHARE PAYABLE IN FULL UPON ACCEPTANCE (“RIGHTS ISSUE WITH WARRANTS”) | (All abbreviations used in this announcement are defined in the announcement dated 23 September 2013)
On behalf of the Company, M&A Securities is pleased to announce that at the close of acceptance, excess application and payment for the Rights Issue with Warrants as at 5.00 p.m. on 14 April 2014 (“Closing Date”), ASIABIO received valid acceptances and excess applications for a total of 454,071,932 Rights Shares. This represents a subscription level of 108.06% of the total number of Rights Shares available under the Rights Issue with Warrants.
Details of valid acceptances and excess applications received as at the Closing Date are as follows:
| No. of Rights Shares
| % of total issue size
| Total valid acceptances
| 197,894,294
| 47.09
| Total valid excess applications
| 256,177,638
| | Total valid acceptances and excess applications
| | | Total Rights Shares available for subscription
| | | Total over subscribed Rights Shares
| 33,871,932
| 8.06
|
As the acceptances and excess applications received exceeded the issue size of 420,200,000 Rights Shares, the issue size of the Rights Issue with Warrants shall be based on the issue size of 420,200,000 Rights Shares and 420,200,000 Warrants.
The Rights Shares and Warrants are expected to be listed on the ACE Market of Bursa Malaysia Securities Berhad on 28 April 2014.
This announcement is dated 18 April 2014. |
本帖最后由 icy97 于 21-4-2014 02:19 AM 编辑
|
|
|
|
|
|
|
|
|
|
|
|
发表于 24-4-2014 03:51 AM
|
显示全部楼层
| ASIA BIOENERGY TECHNOLOGIES BERHAD |
Instrument Type | Warrants | Description | Warrants 2014/2024 issued pursuant to a renounceable rights issue of warrants (“Warrants”) |
Listing Date | 28/04/2014 | Issue Date | 22/04/2014 | Issue/ Ask Price | Not Applicable | Issue Size Indicator | Unit | Issue Size in Unit | 420,200,000 |
Maturity Date | 19/04/2024 | Revised Maturity Date | | Exercise/ Conversion Period | 10.00Year(s) | Revised Exercise/ Conversion Period | | Exercise/Strike/Conversion Price | MYR 0.1000 | Revised Exercise/Strike/Conversion Price | | Exercise/ Conversion Ratio | 1 | Revised Exercise/ Conversion Ratio | | Mode of satisfaction of Exercise/ Conversion price | Cash | Settlement Type/ Convertible into | Physical (Shares) |
| Remarks : | The Warrants may be exercised any time during the tenure of the Warrants of ten (10) years including and commencing from the issue date of the Warrants and ending at 5.00 p.m. on the Expiry Date (being a date being ten (10) years from and including the date of issue of the Warrants, provided that if such day falls on a day which is not a market day, then on the preceding market day). Each Warrant carries the entitlement to subscribe for one (1) new ordinary share of RM0.10 each in Asia Bioenergy Technologies Berhad ("ASIABIO" or "Company") at the Exercise Price which shall be satisfied fully in cash and shall be subject to adjustments in accordance with the Deed Poll.
Subject to the provision in the Deed Poll, the Exercise Price and the number of Warrants held by each Warrant holder shall be adjusted by the Board of Directors of ASIABIO in consultation with the adviser and certification of the external auditors, in the event of alteration to the share capital of the Company. |
Announcement Info| Company Name | ASIA BIOENERGY TECHNOLOGIES BERHAD (ACE Market) | | Stock Name | ASIABIO-WA | | Date Announced | 23 Apr 2014 | | Category | Listing Information & Profile | | Reference No | OS-140414-137AF |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 25-4-2014 03:37 AM
|
显示全部楼层
| ASIA BIOENERGY TECHNOLOGIES BERHAD |
LISTING'S CIRCULAR NO. L/Q : 70365 OF 2014Kindly be advised that ASIABIO's:-
(i) additional 420,200,000 Rights Shares issued pursuant to the Rights Issue with Warrants will be granted listing and quotation with effect from 9.00 a.m., Monday, 28 April 2014; and
(ii) 420,200,000 Warrants issued pursuant to the Rights Issue with Warrants will be admitted to the Official List of Bursa Securities and the listing and quotation of these Warrants on the ACE Market, will be granted with effect from 9.00 a.m., Monday, 28 April 2014.
The Stock Short Name, Stock Number and ISIN Code of the Warrants is as follows:-
Particulars | Warrants | | Stock Short Name | ASIABIO-WA | | Stock Number | 0150WA | | ISIN Code | MYQ0150WAY44 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 25-4-2014 04:22 AM
|
显示全部楼层
Notice of Person Ceasing (29C)| ASIA BIOENERGY TECHNOLOGIES BERHAD |
Particulars of substantial Securities HolderName | CPE Growth Capital Limited | Address | Trident Chambers P.O. Box
146, Road Town, Tortola
British Virgin Islands | NRIC/Passport No/Company No. | 1709460 | Nationality/Country of incorporation | British Virgin Islands | Descriptions (Class & nominal value) | Ordinary Shares of RM0.10 each | Date of cessation | 14/04/2014 | Name & address of registered holder | CPE Growth Capital Limited
Trident Chambers P.O. Box
146, Road Town, Tortola
British Virgin Islands | Currency | Malaysian Ringgit (MYR) | Number of securities disposed | 50,000,000 | Price Transacted ($$) |
| | Circumstances by reason of which a person ceases to be a substantial securities Holder | Disposal of shares | Nature of interest | Direct | Date of notice | 24/04/2014 |
Notice of Interest Sub. S-hldr (29A)
Particulars of Substantial Securities HolderName | CPE Growth Capital Limited | Address | Trident Chambers P.O. Box
146, Road Town, Tortola
British Virgin Islands | NRIC/Passport No/Company No. | 1709460 | Nationality/Country of incorporation | British Virgin Islands | Descriptions (Class & nominal value) | Ordinary Shares of RM0.10 each | Name & address of registered holder | CPE Growth Capital Limited
Trident Chambers P.O. Box
146, Road Town, Tortola
British Virgin Islands |
| Date interest acquired & no of securities acquired | Currency | Malaysian Ringgit (MYR) | Date interest acquired | 22/04/2014 | No of securities | 82,153,000 | Circumstances by reason of which Securities Holder has interest | Subscription to Rights Issue Shares | Nature of interest | Direct | Price Transacted ($$) |
|  | | Total no of securities after change | Direct (units) | 82,153,000 | Direct (%) | 9.78 | Indirect/deemed interest (units) |
| | Indirect/deemed interest (%) |
| | Date of notice | 24/04/2014 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 28-4-2014 09:51 PM
|
显示全部楼层
RM 0.005 的 ASIABIO-WA 要如何得到？是不是要拥有母股，后再买入 附加股 ， 最后 才分到？
假设 母股 8 仙， 附加股 是不是要 10仙？ 是不是一定会成功分到 WA？ |
|
|
|
|
|
|
|
|
|
| |
本周最热论坛帖子
|
2915 
69
